Compare Figs Inc (FIGS) vs Hinge Health Inc. Class A Common Stock (HNGE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Figs Inc vs Hinge Health Inc. Class A Common Stock — how do they compare? Figs Inc trades at $18.6 (market cap $3.10B), while Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.47B). The key difference: Hinge Health Inc. Class A Common Stock is far larger — about 2.7× Figs Inc's market cap, and Figs Inc is more actively traded (5,758,739 versus 1,624,526). Which is the better fit depends on your goals — on Pluang, investors hold Figs Inc for 31 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| FIGS | HNGE | |
|---|---|---|
Market Cap | $3.10B | $8.47B |
Volume | 5,758,739 | 1,624,526 |
Sector | Consumer Cyclical | Health |
52-Week High | $18.63 | $105.14 |
52-Week Low | $7.38 | $31.17 |
Typical Hold Time | 31 Days | 0 Days |
Enterprise Value | $2.86B | $8.09B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FIGS trades at $18.00, up 1.35% with strong technical momentum and bullish moving average signals. The company shows accelerating revenue growth, improving margins, and consistent earnings beats, with Q2 2026 revenue surging 28.8% and international sales up 67%. Recent news highlights international expansion momentum and raised 2026 guidance.
The outlook remains positive with analyst consensus pointing to 26% upside potential, though premium valuation metrics require continued execution. Key risks include rich P/E ratio of 54.6 and execution challenges in maintaining growth momentum amid competitive retail landscape.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Figs Inc
FIGS Inc is a healthcare apparel company. It offers more fitted scrubs for men and women made of its proprietary fabric FIONx, which provides four-way stretch and has anti-odor, anti-wrinkle, and moisture-wicking properties.
Read more on FIGS →About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →
